• Members Area (login)
  • Contact Us
  • Twitter
  • LinkedIn
Pharmabiotic Research Institute (PRI)
    • PRI
      • Home
      • Purpose & People
      • Representation
      • Partnerships
      • Task Groups
      • Members
      • Pharmabiotics Conference
      • Join PRI
    • Microbiome
      • Microbiome Science
      • Regulatory Status
      • Microbiome-based Medicinal Products
    • Regulatory Science
      • EU Landscape
      • Regulatory Framework
      • Regulatory Science & Tools
    • Insights
      • News & Events
      • PRI Publications
      • Member Job Openings
      • Members Area
Select Page
Bio-Me AS

Bio-Me AS

by PRI | Jun 17, 2022 | Microbiome Analysis Expertise (service provider)

Warren Flood CEO Powering Microbiome Research and Diagnostics Development: qPCR-based platform is transforming microbiome analysis by enabling high-volume precision microbiome profiling....
Biofortis

Biofortis

by PRI | Jun 17, 2022 | Microbiome Analysis Expertise (service provider), Microbiome Clinical Research (CRO)

Benoit Fouchaq CEO Biofortis is a unique full services CRO providing Nutrition Clinical Trials, Microbiome Investigation and Data Science for Human and Animal Health....
Next Entries »

Recent News & Events

  • Shaping the future of European biotechnology: PRI’s response to the EU Biotech Act Call for Evidence
  • PRI welcomes Camille Bello as Communication and Membership Manager
  • PRI Board of Director members elects Eleni Tsompanidou as New President
  • Microbiome-based Biomarkers – a multidisciplinary Delphi consensus (The Lancet Microbe)
  • 2024 Pharmabiotics Conference & Partnering – Lille

– Legal Notices –
© PRI 2022. All rights reserved. Copy prohibited unless explicitly authorized. Please contact the PRI.

Pharmabiotic Research Institute (PRI) | European Microbiome Regulatory Science Center
Non-Profit Association (loi 1901) – 1 bis, rue Sénateur Emile Roux, 11100 Narbonne, France

Agence de communication : Frelonbleu